---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-26-000017"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T01:25:08.576879+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q3 revenue +11% to $60.9B, non-GAAP EPS $3.17 (+35%), raises FY26 outlook

## Summary
- Non-GAAP EPS $3.17, up 35% YoY; GAAP EPS $1.69, down 20% on $184M goodwill impairment in Navista & ION.
- Revenue $60.9B, +11%; Pharmaceutical & Specialty segment profit +18% to $784M.
- FY26 non-GAAP EPS guidance raised to $10.70-$10.80; adjusted free cash flow raised to $3.3B-$3.7B.
- Global Medical segment profit fell 36% to $25M due to tariff impact; Other segment profit up 34% to $179M.
- Completed $250M accelerated share repurchase; YTD buybacks $1.0B; leverage ratio lowered to 3.0X.

## SEC filing metadata
- accession: 0000721371-26-000017
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137126000017/0000721371-26-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137126000017/cah-20260430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-26-000017
- JSON: https://secwatch.observer/filing/0000721371-26-000017.json
- Plain text: https://secwatch.observer/filing/0000721371-26-000017.txt

## Key facts
- Earnings Releases
  CARDINAL HEALTH INC reported FY26 results: EPS $10.70 to $10.80. Guidance raised.
  - Period: FY26
  - EPS: $10.70 to $10.80
  - Guidance: raised
  - Result: guidance update
  source text: Cardinal Health is raising and narrowing its fiscal year 2026 guidance for non-GAAP diluted EPS attributable to Cardinal Health, Inc. to a range of $10.70 to $10.80 (+30% to +31% growth).
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000072137126000017/0000721371-26-000017-index.htm
- Earnings Releases
  CARDINAL HEALTH INC reported Q3 FY26 results: revenue $60.9 billion, net income $750 million, EPS $3.17.
  - Period: Q3 FY26
  - Revenue: $60.9 billion
  - Net income: $750 million
  - EPS: $3.17
  - Result: reported results
  source text: Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2026 revenues of $60.9 billion, an increase of 11% from the third quarter of fiscal year 2025. Third quarter GAAP operating earnings decreased 30% to $509 million and GAAP diluted earnings per share (EPS) decreased 20% to $1.69
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000072137126000017/0000721371-26-000017-index.htm
- Earnings Releases
  CARDINAL HEALTH INC reported Q3 FY26 results: revenue $60.9 billion, net income $750 million, EPS $3.17.
  - Period: Q3 FY26
  - Revenue: $60.9 billion
  - Net income: $750 million
  - EPS: $3.17
  - Result: reported results
  source text: to this report. --- EX-99.1 (EX-99.1) --- FOR IMMEDIATE RELEASE Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook • Revenue increased 11% to $60.9 billion • GAAP 1 operating earnings decreased 30% to $509 million; GAAP diluted EPS decreased 20% to $1.69 • Non-GAAP operating earnings increased 18% to $956 million; non-GAAP diluted
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000072137126000017/0000721371-26-000017-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.